| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1998 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1998 | 2019 | |||||||||
|
inflammatory bowel disease 5 | 0.705 | 0.538 |
|
disease | 0.100 | None | 0.917 | 11 | 0 | 2003 | 2014 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2012 | 2019 | |||||||||
|
microRNA 31 | 0.471 | 0.769 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2014 | 2020 | |||||||||
|
inflammatory bowel disease 2 | 0.805 | 0.154 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2000 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2012 | 2019 | |||||||||
|
inflammatory bowel disease 3 | 0.861 | 0.038 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2014 | |||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.450 | None | 0.875 | 5 | 4 | 2009 | 2016 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2011 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1996 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2015 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2012 | 2018 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1998 | 2014 | |||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2017 | |||||||||
|
microRNA 196a-2 | 0.599 | 0.577 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2017 | 2019 | |||||||||
|
inflammatory bowel disease 6 | 0.861 | 0.077 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2015 | |||||||||
|
microRNA 499a | 0.519 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2019 | |||||||||
|
suppression of tumorigenicity 2 | 0.576 | 0.692 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2017 | |||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2020 |